Rep. Gilbert Ray Cisneros, Jr. Buys Zoetis Inc. (NYSE:ZTS) Stock

Posted by Linda Flegge on Dec 19th, 2025

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on December 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in Zoetis stock on November 18th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 11/26/2025.
Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 11/26/2025.
Purchased $1,001 – $15,000 in shares of First Watch Restaurant Group (NASDAQ:FWRG) on 11/26/2025.
Purchased $1,001 – $15,000 in shares of TKO Group (NYSE:TKO) on 11/26/2025.
Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 11/24/2025.
Sold $1,001 – $15,000 in shares of Stifel Financial (NYSE:SF) on 11/24/2025.
Purchased $1,001 – $15,000 in shares of Logan Energy (CVE:LGN) on 11/24/2025.
Sold $1,001 – $15,000 in shares of Primoris Services (NASDAQ:PRIM) on 11/24/2025.
Purchased $15,001 – $50,000 in shares of LandBridge (NYSE:LB) on 11/21/2025.
Purchased $50,001 – $100,000 in shares of LandBridge (NYSE:LB) on 11/20/2025.

Zoetis Trading Down 0.3%

ZTS traded down $0.42 during trading on Friday, reaching $122.34. 11,217,637 shares of the company’s stock were exchanged, compared to its average volume of 3,463,560. The company’s fifty day moving average price is $129.24 and its 200-day moving average price is $144.98. The firm has a market capitalization of $53.91 billion, a PE ratio of 20.60, a P/E/G ratio of 2.66 and a beta of 0.97. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.40. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64.

Zoetis (NYSE:ZTS – Get Free Report) last released its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Tuesday, January 20th. Zoetis’s payout ratio is presently 35.69%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. The Goldman Sachs Group raised shares of Zoetis to a “buy” rating in a research report on Monday. Barclays initiated coverage on shares of Zoetis in a report on Monday, December 8th. They issued an “equal weight” rating and a $136.00 price target for the company. KeyCorp assumed coverage on shares of Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating for the company. Finally, Argus reiterated a “buy” rating and set a $190.00 target price on shares of Zoetis in a report on Tuesday, September 9th. Six research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $160.18.

Check Out Our Latest Report on Zoetis

Hedge Funds Weigh In On Zoetis

Large investors have recently added to or reduced their stakes in the company. Lindenwold Advisors INC bought a new stake in shares of Zoetis in the third quarter valued at about $2,449,000. Academy Capital Management bought a new position in shares of Zoetis during the third quarter worth about $12,908,000. Alecta Tjanstepension Omsesidigt raised its position in Zoetis by 24.3% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 882,200 shares of the company’s stock valued at $129,022,000 after buying an additional 172,300 shares during the last quarter. Swiss Life Asset Management Ltd lifted its stake in Zoetis by 11.3% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 145,691 shares of the company’s stock valued at $21,318,000 after acquiring an additional 14,744 shares in the last quarter. Finally, Tevis Investment Management lifted its stake in Zoetis by 5.8% in the 3rd quarter. Tevis Investment Management now owns 3,054 shares of the company’s stock valued at $447,000 after acquiring an additional 167 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Zoetis

(Get Free Report)

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.